Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Oncternal Therapeutics, Inc./ S-8 POS

SEC Filing · S-8 POS

Oncternal Therapeutics, Inc.

SEC Filing

Filed Mar 27, 2025Accepted Mar 27, 2025, 2:17 AM EDTCIK 1260990Accession 0001193125-25-064623
View company →Permanent SEC source ↗
Share

Recent company filings

  1. EFFECT filingMar 31, 2025
  2. EFFECT filingMar 31, 2025
  3. EFFECT filingMar 31, 2025
  4. EFFECT filingMar 31, 2025
  5. EFFECT filingMar 31, 2025

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗